Semaglutide treatment decreases stroma development and allows T lymphocyte infiltration in ex vivo and in vivo models of PDAC developing upon metabolic syndrome To further explore the active role of P4HA1 role in stroma development, data related to P4HA1 and immune cell signature [55] gene expression levels of PDAC patients deposited in TCGA data portal were correlated, revealing that P4HA1 expression enrichment associates with decreased T lymphocyte signature expression (Fig
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al
Will I have to do phone or video appointments
This typically includes: Body weight to assess early response to treatment Blood glucose levels particularly if you have type 2 diabetes or are taking glucose-lowering medicines Renal and hepatic function as part of routine safety monitoring Gastrointestinal symptom burden to determine whether dose escalation can proceed as planned If side effects remain troublesome beyond the first week, your clinician may delay dose escalation or provide additional supportive measures
- Em caso de hipersensibilidade ao produto, recomenda-se descontinuar o uso e consultar o mdico
